Tumor development at the site of ureterointestinal anastomosis is a recognized complication in patients undergoing ureterosigmoidostomy. In order to explore the hypothesis that carcinogens (nitrosamines) may be a factor in ureterosigmoidostomy, female Sprague-Dawley rats (n = 125) underwent urethral ligation, bladder dome resection and anastomosis of the bladder trigone to an opening in the anterior rectosigmoid wall. Biweekly nitrosamine determinations were performed on the resultant urine-feces slurry by gas chromatography up to thirty-two weeks post surgery. Nitrosamine (N,N-dimethylnitrosamine) was noted as early as two weeks after surgery in 39% (11/28) of rats. One hundred percent of animals consistently demonstrated nitrosamine by week 14 (32 rats). Nitrosamine levels increased throughout the study with a peak level after thirty-two weeks of 0.275 micrograms./ml. Only a portion (n = 40) of the total animal population was deemed suitable for pathologic examination secondary to animal demise and autolysis at autopsy related to infection and obstruction. In these animals, no adenocarcinoma was found although hyperplastic changes and metaplastic changes were demonstrable at nine days and eight weeks respectively. In one animal a grade I transitional cell papilloma was identified after eight weeks. Control animals demonstrated no nitrosamine production. In vitro combinations of rat urine and feces yielded nitrosamine after six weeks. The absence of adenocarcinoma tumor development is believed indirectly related to animal demise in that not enough time had elapsed to allow significant tumor development. This study lends support to the concept that nitrosamines may play a role in the development of hyperplasia, dysplasia and eventual neoplasia in ureterosigmoidostomy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0022-5347(17)43184-3DOI Listing

Publication Analysis

Top Keywords

tumor development
12
thirty-two weeks
8
demonstrated nitrosamine
8
animal demise
8
nitrosamine
6
weeks
6
animal
5
urinary carcinogen
4
carcinogen [nitrosamine]
4
[nitrosamine] production
4

Similar Publications

Confined cell migration along extracellular matrix space in vivo.

Proc Natl Acad Sci U S A

January 2025

Center for Complexity and Biosystems, Department of Environmental Science and Policy, University of Milan, 20133 Milan, Italy.

Collective migration of cancer cells is often interpreted using concepts derived from the physics of active matter, but the experimental evidence is mostly restricted to observations made in vitro. Here, we study collective invasion of metastatic cancer cells injected into the mouse deep dermis using intravital multiphoton microscopy combined with a skin window technique and three-dimensional quantitative image analysis. We observe a multicellular but low-cohesive migration mode characterized by rotational patterns which self-organize into antiparallel persistent tracks with orientational nematic order.

View Article and Find Full Text PDF

Malignant gliomas are heterogeneous tumors, mostly incurable, arising in the central nervous system (CNS) driven by genetic, epigenetic, and metabolic aberrations. Mutations in isocitrate dehydrogenase (IDH1/2) enzymes are predominantly found in low-grade gliomas and secondary high-grade gliomas, with IDH1 mutations being more prevalent. Mutant-IDH1/2 confers a gain-of-function activity that favors the conversion of a-ketoglutarate (α-KG) to the oncometabolite 2-hydroxyglutarate (2-HG), resulting in an aberrant hypermethylation phenotype.

View Article and Find Full Text PDF

Dysregulation of GABAergic inhibition is associated with pathological pain. Consequently, enhancement of GABAergic transmission represents a potential analgesic strategy. However, therapeutic potential of current GABA agonists and modulators is limited by unwanted side effects.

View Article and Find Full Text PDF

Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive sarcomas and the primary cause of mortality in patients with neurofibromatosis type 1 (NF1). These malignancies develop within preexisting benign lesions called plexiform neurofibromas (PNs). PNs are solely driven by biallelic loss eliciting RAS pathway activation, and they respond favorably to MEK inhibitor therapy.

View Article and Find Full Text PDF

Computational-aided rational mutation design of pertuzumab to overcome active HER2 mutation S310F through antibody-drug conjugates.

Proc Natl Acad Sci U S A

January 2025

Laboratory of Precision Medicine and Biopharmaceuticals, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.

Recurrent missense mutations in the human epidermal growth factor receptor 2 (HER2) have been identified across various human cancers. Among these mutations, the active S310F mutation in the HER2 extracellular domain stands out as not only oncogenic but also confers resistance to pertuzumab, an antibody drug widely used in clinical cancer therapy, by impeding its binding. In this study, we have successfully employed computational-aided rational design to undertake directed evolution of pertuzumab, resulting in the creation of an evolved pertuzumab variant named Ptz-SA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!